-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the afternoon of the 3rd, the CPPCC held the 43rd bi-weekly consultation symposium in Beijing, focusing on the "quality problems and countermeasures of generic drugs" advice. Yu Zhengsheng, chairman of the National Committee of the Chinese People's Political Consultative Conference (CPPCC) presided over the meeting and made a speech.
CPPCC National Committee members He Wei, Jiang Zujun, Cai Wei, Yan Yiming, Chen Kaixian, Zhou Ran, Niu Guangming, Liu Wenwei, Qu Fenghong, Hua Yawei, Duan Huijun, Hou Yanning, Wen Jianmin, as well as experts and scholars Li Dagui, Song Ruixuan and Xiao Hong spoke at the symposium.
committee members believe that improving the quality of generic drugs is a major event, related to the health of the people, related to the sustainability of health care, related to whether the people can use high-quality and cheap generic drugs. The CPC Central Committee and the State Council attach great importance to the quality of medicines. The relevant departments of the central government have continuously strengthened policy guidance and supervision efforts to promote the improvement of the quality and standards of generic drugs. At present, generic drugs basically meet the needs of the public, but also face the quality of generic drugs is uneven, imitation standards are low, some of the drug efficacy is not accurate and so on. We should further strengthen reform and policy adjustment efforts to improve the quality of medicines and ensure the safety of drug use.
some members suggested that the first is to raise drug approval standards, encourage drug research and development, simplify procedures and speed up approval. Second, accelerate the evaluation of the quality of generic drugs, further improve the standards, eliminate backwardness. Drugs that are evaluated consistently are allowed to be labeled on the outer packaging, prioritized procurement by medical institutions, and supported in technical transformation. Third, the health insurance policy and tender policy should be conducive to the use of high-quality generic drugs. We should adjust drug policy in a timely manner, optimize the medical insurance catalogue, improve the relevant system of drug bidding and procurement, and give full play to the role of medical insurance leverage. Fourth, improve hospital management, improve hospital assessment methods, implement medical care, medical insurance, medicine linkage, improve the incentive mechanism to encourage the use of high-quality generic drugs, and effectively protect the people's health rights and interests. Fifth, attach importance to generic drug innovation, strengthen post-market supervision, and promote the upgrading of the pharmaceutical industry.
, Director General of the State Food and Drug Administration, introduced the situation. Xin Guobin, Vice Minister of Industry and Information Technology, Yu Yu, Vice Minister of Human Resources and Social Security, and Liu Qian, Deputy Director of the National Health and Family Planning Commission, attended the meeting and interacted with members. The CPPCC is very concerned about the quality of generic drugs. Previously, many CPPCC members put forward suggestions through proposals and other forms, the Central Committee of the Agricultural Labour Party, the CPPCC Committee on Education, Science, Cultural and Health carried out a special study.
, Zhang Qingli, Lu Zhanggong and Liu Xiaofeng, vice chairman of the National Committee of the Chinese People's Political Consultative Conference (CPPCC) attended the symposium. (Chinese Government Network)